MRSA bacterium and Destiny Pharma logo
An emerging crisis of antibiotic resistance

"We are in the midst of an emerging crisis of antibiotic resistance for microbial pathogens in the United States and throughout the world." (IDSA 2007)

"The potential crisis at hand is the result of a marked decrease in industry R&D, government inaction, and the increasing prevalence of resistant bacteria. Infectious diseases physicians are alarmed by the prospect that effective antibiotics may not be available to treat seriously ill patients in the near future." (Bad Bugs, No Drugs IDSA 2004)